Finance

Lists
Why is IBIO down 5,33%?
Dive Deeper
IBIO:NASDAQ
Ibio Inc
USD 0,87
-5,33%
(-0,049) 1D
USD 0,86
-0,86% (-0,0075)
After hours
Closed: 9 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBIO...
Open
USD 0,92
High
USD 0,97
Low
USD 0,85
Mkt. cap
56,01 m
Avg. vol.
696,48 k
Volume
1,65 m
52-wk high
USD 3,82
52-wk low
USD 0,78
EPS
-USD 0,32
Beta
1,26
Shares outstanding
64,31 m
No. of employees
23
Open
USD 0,92
High
USD 0,97
Low
USD 0,85
Mkt. cap
56,01 m
Avg. vol.
696,48 k
Volume
1,65 m
52-wk high
USD 3,82
52-wk low
USD 0,78
EPS
-USD 0,32
Beta
1,26
Shares outstanding
64,31 m
No. of employees
23
News stories
From web sources and news partners
About Ibio Inc
CEO-
Employees23
Founded2008
Headquarters-
Sector-
Websiteibioinc.com
Analyst ratings
Based on 3 analysts giving stock ratings to IBIO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for IBIO in the last 3 months.
Highest
Current USD 0,87
USD 7,00 (+703,67%)
Average
USD 6,00 (+588,86%)
Lowest
USD 5,00 (+474,05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Reiterated
USD 7,00
+703,7%
10/02/2026
William Wood
B. Riley Securities
Buy
Initiated
USD 6,00
+588,9%
08/31/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
USD 5,00
+474,1%
08/28/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
USD 5,00
+474,1%
07/01/2026
Martin Auster
Raymond James
Buy
Initiated
USD 5,00
+474,1%
06/08/2026
Roanna Ruiz
Leerink Partners
Buy
Maintained
USD 6,00
+588,9%
05/15/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
USD 6,00
+588,9%
05/14/2026
Catherine Novack
JonesTrading
Buy
Maintained
USD 7,00
+703,7%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
100,00 k
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,55 m
4,28 m
3,25 m
8,56 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,50 m
5,16 m
5,11 m
-2,18 m
Operating expense
6,05 m
9,44 m
8,36 m
6,38 m
Total operating expenses
6,05 m
9,44 m
8,36 m
6,38 m
Operating income
-5,95 m
-9,44 m
-8,36 m
-6,38 m
Other non operating income
-
-
-
-
EBT including unusual items
-5,72 m
-8,99 m
-7,73 m
-10,60 m
EBT excluding unusual items
-5,72 m
-8,99 m
-7,73 m
-5,60 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,72 m
-8,99 m
-7,73 m
-10,60 m
Net profit margin
-5 720,00%
-
-
-
Earnings per share
-0,11
-0,09
-0,06
-0,07
Interest and investment income
267,00 k
493,00 k
657,00 k
779,00 k
Interest expense
-36,00 k
-41,00 k
-22,00 k
-
Net interest expenses
231,00 k
452,00 k
635,00 k
779,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,76 m
-9,30 m
-8,21 m
-6,22 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme